Ruijin Hospital
Clinical trials sponsored by Ruijin Hospital, explained in plain language.
-
New hope for rare inflammatory disease: sirolimus shows promise in small trial
Disease control OngoingThis study looks at whether sirolimus, a drug that calms the immune system, can help people with Adult-Onset Still's disease that hasn't improved with standard treatments. Three adults with this rare inflammatory condition will take sirolimus pills for 12 weeks while doctors moni…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 04:01 UTC
-
New drug combo shows promise for shrinking stomach tumors before surgery
Disease control OngoingThis study tests whether adding two drugs (camrelizumab and apatinib) to standard chemotherapy before surgery can help shrink tumors in people with advanced stomach or gastroesophageal junction cancer. About 80 participants will receive the treatment before their planned surgery.…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 04:00 UTC
-
Heart bypass drug combo trial pulled before it even started
Disease control TerminatedThis study aimed to see if taking two blood-pressure medicines (isosorbide mononitrate and amlodipine) for 24 weeks after heart bypass surgery could prevent the radial artery graft from failing. It planned to enroll adults who had just received a radial artery graft during bypass…
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
One-Week radiation shows promise for breast cancer control
Disease control OngoingThis study tests a one-week course of radiation for breast cancer patients who need treatment to the chest or breast and nearby lymph nodes. The goal is to see if this shorter approach is safe and effective at controlling the disease. About 197 participants will be followed for a…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New drug CS01 tested in advanced cancer patients
Disease control OngoingThis early-phase trial tests the safety and effectiveness of a new drug called CS01 in up to 10 people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first finding a safe dose, then checking if the drug can shrink tumors. It is…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New hope for hepatitis b patients with normal ALT: TMF trial underway
Disease control OngoingThis study tests a drug called TMF (amibufenamide) in 200 adults with chronic hepatitis B who have normal liver enzyme (ALT) levels. The goal is to see if TMF can lower the amount of hepatitis B virus in the blood to undetectable levels after 48 weeks. Participants are randomly a…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Heart bypass patients get new hope: three-drug trial aims to keep arm artery grafts open longer
Disease control OngoingThis study compares three oral medications (nicorandil, diltiazem, and isosorbide mononitrate) to prevent spasms in radial artery grafts used in coronary artery bypass surgery. About 150 adults who recently had this surgery will take one of the drugs for 24 weeks, with follow-up …
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Real-World data shows promise for CNCT-19 in tough leukemia
Disease control OngoingThis study looks at how well a treatment called CNCT-19 works for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). Researchers will review medical records from 275 patients in China to see how many achieve remission and how long it lasts. The g…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug combo shows promise in stomach cancer battle
Disease control OngoingThis study tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy and apatinib can improve outcomes for people with stomach or gastroesophageal junction cancer. About 580 adults with locally advanced but removable tumors will receive the treatment befor…
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Can a simple pill delay Parkinson's? new study tests idebenone in sleep disorder patients
Disease control OngoingThis study tests whether the drug idebenone can slow or prevent the progression of a sleep disorder called iRBD into more serious brain diseases like Parkinson's. About 142 adults with iRBD will receive either idebenone or a placebo for up to 5 years. Researchers will track how m…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immune test may fine-tune virus prevention in transplant patients
Disease control OngoingThis study tests whether a blood test that measures CMV-specific immunity can help doctors decide how long to use the antiviral drug letermovir after a stem cell transplant. The goal is to prevent late-onset CMV infection, a common complication. The trial involves 250 adults rece…
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New heart test could make diagnosis faster and easier
Diagnosis OngoingThis study looks at a new method called UFR to find significant blockages in heart arteries. It involves 112 adults with suspected heart disease. The goal is to see if UFR works as well as the current standard test (FFR) to guide treatment decisions.
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated May 22, 2026 13:55 UTC
-
Can a natural oil stop bedsores before they start?
Prevention ENROLLING_BY_INVITATIONThis study tests if a natural oil (palmitoleic acid) applied to the skin can prevent pressure injuries (bedsores) in 60 hospital patients at high risk. Researchers will use special scanners to detect early signs of skin damage before it becomes visible. The goal is to see if the …
Phase: NA • Sponsor: Ruijin Hospital • Aim: Prevention
Last updated May 18, 2026 12:08 UTC
-
New brain zapping technique targets tough depression
Symptom relief OngoingThis study tests a new type of brain stimulation for people with depression that hasn't improved with standard treatments. Ten adults will receive both active and sham (fake) stimulation in random order to see if the real treatment reduces symptoms. The goal is to find a safe and…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 26, 2026 03:53 UTC
-
Zap away tremors? new brain stimulation trial for Parkinson's
Symptom relief ENROLLING_BY_INVITATIONThis study tests a non-invasive brain stimulation technique called tTIS to see if it can improve movement problems in people with early to mid-stage Parkinson's disease. Researchers will compare two different brain targets (STN and GPi) in the same person to find which works bett…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Could a gentle brain zapping boost memory in early Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new, non-invasive brain stimulation method called Temporal Interference Stimulation (TIS) in 40 people with early-stage Alzheimer's. Participants will receive either real TIS or a sham (fake) treatment for 2 weeks. Researchers will check thinking skills and saf…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Zapping the Brain's fear center to lift depression fast
Symptom relief ENROLLING_BY_INVITATIONThis study tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (TIS) aimed at the right amygdala to quickly reduce depression symptoms. Fifty adults with major depressive disorder will receive either real or sham stimulation over…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Researchers look back at leukemia Drug's Real-World results
Knowledge-focused OngoingThis study looks back at medical records of 102 adults with B-cell acute lymphoblastic leukemia who received the drug inotuzumab ozogamicin. The goal is to see how well the drug worked and how safe it was in different patient groups. No new treatments are given; researchers simpl…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:55 UTC
-
New imaging technique may reduce heart surgery complications
Knowledge-focused OngoingThis study involves 792 people who need heart valve surgery and also have blocked coronary arteries. Researchers are comparing two ways to decide which blockages to treat during surgery: standard angiography (X-ray dye pictures) versus a newer computer analysis called Quantitativ…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC
-
New index aims to level the playing field for gastric cancer surgery evaluations
Knowledge-focused OngoingThis study creates a new tool called the SAH Index to fairly compare how well different hospitals perform gastric cancer surgery. Researchers analyzed medical records from 780 patients who had surgery in 2019, considering factors like age, tumor type, and genetic markers. The goa…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:47 UTC
-
New imaging tool tracks lung health in real time for ICU patients
Knowledge-focused OngoingThis study looks at 120 adults with severe breathing failure (ARDS) who are on a ventilator. Researchers use a non-invasive imaging tool called electrical impedance tomography (EIT) to watch how air and blood flow move through the lungs over time. The goal is to see if different …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
AI and PET scans join forces to spot lung trouble in rare muscle disease
Knowledge-focused OngoingThis study aims to create a new way to diagnose interstitial lung disease (ILD) in people with dermatomyositis, a rare muscle condition. Researchers will use special PET/CT scans and machine learning to find patterns that predict ILD. The study involves 200 adults and compares th…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
New lung imaging tool may predict oxygen therapy failure
Knowledge-focused OngoingThis study looks at whether a special imaging technique called Electrical Impedance Tomography (EIT) can help doctors know if high-flow oxygen therapy will stop working within 48 hours. About 90 adults with acute breathing problems will be monitored. The goal is to find a better …
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC
-
Scientists hunt for sepsis clues in blood gene activity
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at a gene called TRIM25 in blood cells from 65 hospitalized adults with and without sepsis. By comparing gene activity and inflammatory markers, researchers hope to find new ways to diagnose and treat sepsis. Participants give blood samples, and no experimental t…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC